Mounjaro (tirzepatide) has generated extraordinary clinical results since its approval. Where Ozempic and Wegovy target a single hormonal pathway, Mounjaro activates two — and the combination produces weight loss numbers that were previously only achievable through bariatric surgery. This guide covers exactly how it works, the correct dose escalation for Nigerian patients, what to expect in terms of side effects, and the clinical evidence behind the headlines.
What Is Tirzepatide?
Tirzepatide is the active molecule in Mounjaro (and in Zepbound, the same drug approved specifically for obesity in some markets). It is a dual GIP/GLP-1 receptor agonist — a single molecule that activates both the GLP-1 (glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor simultaneously.
GLP-1 activation you may already know: it reduces appetite, slows gastric emptying, and signals satiety. GIP activation adds a separate and synergistic layer — it appears to improve how the body responds to GLP-1 signalling, amplify fat-burning in adipose tissue, and potentially reduce the nausea associated with GLP-1 activation alone. The result is a medication that consistently outperforms pure GLP-1 agonists in head-to-head comparisons.
The Clinical Evidence: SURMOUNT Trials
Eli Lilly's SURMOUNT trial series is the most rigorous weight loss drug evidence base published to date. The key results:
SURMOUNT-1 (72 weeks)
2,539 adults without diabetes. Tirzepatide 15 mg produced a mean 22.5% reduction in body weight — equivalent to roughly 23 kg for a 100 kg patient. 91% of participants achieved at least 5% weight loss. One-third achieved over 25% weight loss.
SURMOUNT-2 (72 weeks)
Adults with type 2 diabetes. Even in this population (which historically shows more modest weight loss with GLP-1 drugs), tirzepatide 15 mg produced 15.7% mean body weight reduction — significantly better than semaglutide 1 mg comparator arms in similar studies.
Context for Nigerian patients: A 100 kg patient achieving 22% weight loss is a reduction of 22 kg — bringing them to 78 kg. For most Nigerians with obesity-related hypertension, sleep apnoea, or pre-diabetes, this level of weight loss produces dramatic improvements in cardiovascular and metabolic risk factors.
Mounjaro Dosing Schedule
Like all GLP-1 class medications, Mounjaro requires a gradual dose escalation. The schedule is non-negotiable — jumping doses dramatically increases nausea risk and dropout rates.
| Phase | Dose | Duration |
|---|---|---|
| Starter | 2.5 mg weekly | 4 weeks |
| Step 1 | 5 mg weekly | 4 weeks minimum |
| Step 2 | 7.5 mg weekly | 4 weeks minimum |
| Step 3 | 10 mg weekly | 4 weeks minimum |
| Step 4 | 12.5 mg weekly | 4 weeks minimum |
| Maximum | 15 mg weekly | Maintenance |
Not all patients need to reach 15 mg. Many achieve excellent results at 5–10 mg. The goal is to find the lowest dose at which you're achieving consistent, meaningful weight loss without intolerable side effects. Some patients remain on 5 mg for months and continue losing weight steadily.
Can I Stay on a Lower Dose?
Yes — and this is important for Nigerian patients balancing cost and efficacy. The SURMOUNT data shows dose-dependent results, but the 5 mg dose still produced an average 15% body weight reduction in many participants. If 5 mg or 7.5 mg is working for you and you are tolerating it well, there is no clinical requirement to push to the maximum dose.
Side Effects of Mounjaro
The side effect profile is very similar to other GLP-1 medications. The most common effects are gastrointestinal.
Common (affecting more than 1 in 10 patients)
- Nausea — typically worst in the first 4–8 weeks and at each dose increase. Eating smaller, lower-fat meals helps significantly.
- Diarrhoea — more common than with semaglutide in some patients. Stay hydrated.
- Constipation — particularly common at lower dose levels. Increase fibre and fluid intake.
- Reduced appetite — this is the intended effect, but some patients find it initially surprising. Ensure you are still meeting protein and micronutrient targets.
- Vomiting — usually related to eating too quickly or consuming trigger foods. Improves within a few weeks.
Less Common Effects
- Injection site reactions (redness, bruising) — rotate sites to manage
- Fatigue, particularly early in treatment
- Mild hair thinning (associated with rapid weight loss generally, not specific to tirzepatide)
- Heartburn / GERD in patients with pre-existing reflux
Stop and seek medical help immediately if: You experience severe, persistent abdominal pain (especially if it radiates to the back — this may indicate pancreatitis), a lump or swelling in the neck, difficulty swallowing, signs of severe allergic reaction, or significant changes in vision.
Mounjaro vs Ozempic: The Key Difference for Nigerian Patients
The most clinically meaningful difference is average weight loss outcome. Mounjaro at 15 mg produces roughly double the weight loss of Ozempic at 1 mg. For a patient who is 40 kg above their target weight, this difference is the gap between a partial improvement and a transformative outcome.
The practical differences to weigh in Nigeria are:
- Cost: Mounjaro pens typically cost more in Nigeria than Ozempic. However, given the superior weight loss, the cost-per-kg-lost may actually be comparable or favourable for Mounjaro at higher doses.
- Pen design: Mounjaro comes in single-use KwikPen devices. Each pen is a single dose. This is simpler to use than Ozempic's multi-dose dial pen, which requires attaching needles and dose selection.
- Storage: Both require refrigeration (2–8°C). Cold-chain requirements are identical.
Who Is Mounjaro Most Suitable For?
- Patients with significant obesity (BMI 30+, or 27+ with a weight-related condition) seeking the maximum available pharmacological intervention
- Patients with type 2 diabetes who also need weight management
- Patients who have tried semaglutide and reached a plateau
- Patients targeting specific health outcomes (blood pressure reduction, improved lipid profile, reduced HbA1c) alongside weight loss
How to Get Mounjaro in Nigeria
Mounjaro is available through WeightLoss NG in Lagos, Abuja, and Port Harcourt. We stock all dose strengths (2.5 mg through 15 mg) and maintain verified cold-chain storage and delivery. All orders are dispensed by a PCN-licensed pharmacist with a brief clinical consultation to confirm suitability.
Order Mounjaro in Nigeria
All strengths available. Cold-chain guaranteed. Pharmacist consultation included. Order via WhatsApp in under 2 minutes.
Order Mounjaro via WhatsApp